Home/Filings/4/0001209191-12-045117
4//SEC Filing

Keller Joseph Kenneth 4

Accession 0001209191-12-045117

CIK 0000831547other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 4:55 PM ET

Size

9.2 KB

Accession

0001209191-12-045117

Insider Transaction Report

Form 4
Period: 2012-09-07
Keller Joseph Kenneth
EVP & Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-09-07+300,000300,000 total
    Exercise: $12.01From: 2012-09-07Exp: 2022-09-07Common Stock (300,000 underlying)
  • Award

    Common Stock, $0.001 par value

    2012-09-07+20,00028,000 total
  • Award

    Common Stock, $0.001 par value

    2012-09-07+100,000128,000 total
Footnotes (3)
  • [F1]50% of the restricted shares will vest on March 1, 2013 and the remaining 50% on September 1, 2013.
  • [F2]25% of the restricted shares will vest on September 1, 2013 and an additional 25% on each anniversary therafter over three years.
  • [F3]25% of the option shares shall vest on September 7, 2013. The remaining option shares shall vest thereafter in equal monthly amounts over three years.

Issuer

SPECTRUM PHARMACEUTICALS INC

CIK 0000831547

Entity typeother

Related Parties

1
  • filerCIK 0001557759

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:55 PM ET
Size
9.2 KB